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ABSTRACT 
Synthesis of a Water Soluble Resveratrol Derivative as a Potential Anti-Cancer Drug 
by 
Augustine Foster Essel 
 
Research on development of water soluble anti-cancer drugs is one of the great challenges of 
modern medicinal chemistry. Resveratrol (Res) is one of the many phytoalexins producing 
stilbenoids present in several medicinal plants, grape skin, peanuts, and red wine. It has been 
found to exhibit anti-cancer, anti-inflammatory, and anti-oxidant properties. Water solubility and 
bioavailability are some of the setbacks of this interesting compound. In view of this, effort has 
been made to synthesize amino acid derivative of resveratrol to improve its bioavailability and 
solubility in water. Methyl 4-{-[(1E)-2-(3, 5-dihydroxyphenyl)-ethenyl] - phenoxy} butyrate (7), 
a novel ester intermediate, has been synthesized and  could be subjected to further chemical 
transformations to obtain amino acid derivatives.  
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CHAPTER 1 
INTRODUCTION 
Research on development of water soluble anti-cancer drugs is one of the great 
challenges of modern medicinal chemistry. In view of this, effort has been made to synthesize 
water soluble resveratrol derivatives. 
Biology of Cancer 
Naturally, our body cells are programmed to divide, grow, and die. Damage to DNA can 
cause cells to experience uncontrolled growth and, therefore, damage to the genes involved in 
cell division. The four key types of genes which are responsible  for the cell division process are: 
oncogene, which  tell cells when to divide, tumor suppressor genes tell cells when not to divide, 
suicide genes control apoptosis and tell the cell to kill itself if something goes wrong, and DNA-
repair genes instruct a cell to repair damaged DNA [1] . Cancer occurs when a cell's gene 
mutations make the cell unable to correct DNA damage and unable to commit suicide [1]. 
Carcinogens are a group of substances that cause   damage to DNA, promoting or aiding 
cancer. Tobacco, asbestos, arsenic, radiation such as gamma and x-rays, the sun, and compounds 
in car exhaust fumes are all examples of carcinogens [1]. When our bodies are exposed to 
carcinogens, free radicals are produced that in turn react with other molecules in the body. There 
are five broad groups that are used to classify cancer [1]. 
1. Carcinomas are characterized by cells that cover internal and external parts of the body 
such as lung, breast, and colon cancer. 
2. Sarcomas are characterized by cells that are located in bone, cartilage, fat, connective 
tissue, muscle, and other supportive tissues. 
3. Lymphomas are cancers that begin in the lymph nodes and immune system tissues. 
4. Leukemia is cancers that begin in the bone marrow and often accumulate in the 
bloodstream. 
5. Adenomas are cancers that arise in the thyroid, the pituitary gland, the adrenal gland, and 
other glandular tissues. 
Cancer Treatment 
One of the following six categories can be used as a treatment method for cancer: 
surgery, radiation, chemotherapy, immunotherapy, hormone therapy, and gene therapy.  
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Surgery  
 This kind of cancer treatment is useful at the onset of the cancer cells when they have 
not spread to other part of the body. In this case it is possible to completely cure a patient by 
surgically removing the cancer from the body. This is often seen in the removal of the prostate or 
a breast or testicle. After the disease has spread, however, it is nearly impossible to remove all of 
the cancer cells. Surgery may also be instrumental in helping to control symptoms such as bowel 
obstruction or spinal cord compression [1]. 
Radiotherapy 
Radiation treatment also known as radiotherapy kills cancer cells by using or exposing 
high-energy rays on the cancer cells. High energy rays causes damage to the molecules that make 
up the cancer cells and lead them to commit suicide. Radiotherapy uses high-energy gamma-rays 
that are emitted from metals such as radium or high-energy x-rays that are created in a special 
machine. Early radiation treatments caused severe side-effects because the energy beams damage 
normal, healthy tissue, but technologies have improved so that beams can be more accurately 
targeted. Radiotherapy is used as a standalone treatment to shrink a tumor or destroy cancer cells 
(including those associated with leukemia and lymphoma), and it is also used in combination 
with other cancer treatments [1]. 
Immunotherapy 
Immunotherapy aims to get the body's immune system to fight the tumor. Systemic 
immunotherapy treats the whole body by administering an agent such as the protein interferon 
alpha that can shrink tumors. Immunotherapy can also be considered non-specific if it improves 
cancer-fighting abilities by stimulating the entire immune system, and it can be considered 
targeted if the treatment specifically tells the immune system to destroy cancer cells. These 
therapies are relatively young, but researchers have had success with treatments that introduce 
antibodies to the body that inhibit the growth of breast cancer cells. Bone marrow transplantation 
(hematopoietic stem cell transplantation) can also be considered immunotherapy because the 
donor's immune cells will often attack the tumor or cancer cells that are present in the host [1]. 
Gene Therapy 
The objective of gene therapy is to replace damaged genes with ones that work to 
remove a root cause of cancer, damage to DNA. Interesting research are been done to replace the 
damaged gene that signals cells to stop dividing (the p53 gene) with a copy of a working gene. 
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Other gene-based therapies focus on further damaging cancer cell DNA to the point where the 
cell commits suicide [1]. 
Chemotherapy  
Chemist plays an important role when it comes to chemotherapy and intense research is 
being done to develop potent chemotherapeutic drugs. Chemotherapy uses chemicals that 
interfere with the cell division process - damaging proteins or DNA - so that cancer cells will 
commit suicide. These treatments target any rapidly dividing cells (not necessarily just cancer 
cells), but normal cells usually can recover from any chemical-induced damage while cancer 
cells cannot. Chemotherapy is generally used to treat cancer that has spread or metastasized 
because the medicines travel throughout the entire body. It is a necessary treatment for some 
forms of leukemia and lymphoma. Chemotherapy treatment occurs in cycles so the body has 
time to heal between doses. However, there are still common side effects such as hair loss, 
nausea, fatigue, and vomiting. Combination therapies often include multiple types of 
chemotherapy or chemotherapy combined with other treatment options [1]. 
Natural Compounds with Health Benefits 
Polyphenols 
Polyphenols are naturally occurring compounds that have been found to affect cancer 
cell growth and they have attracted great research attention.  Initial evidence came from 
epidemiologic studies suggesting that a diet that includes regular consumption of fruits and 
vegetables (rich in polyphenols) significantly reduces the risk of many cancers [2]. The anti- 
cancer properties of polyphenols can be attributed to their ability to act as anti-oxidants, and also 
to their ability to interact with basic cellular mechanisms. These cellular interactions include 
interference with membrane and intracellular receptors, modulation of signaling cascades, 
interaction with the basic enzymes involved in tumor promotion and metastasis, interaction with 
oncogene, and oncoproteins [2]. Their great properties could be significantly exploited in the 
field of oncology. 
Classification and Nomenclature of Polyphenols 
Polyphenols are classified by the presence of more than one phenol unit or building 
block per molecule.  Generally, they are divided into hydroxylable tannins, phenylpropanoid 
such as lignin, and flavonoids as shown in Figure 1 [3]. 
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The type of phenonic subcomponent could also be used as a basis for classifying 
Polyphenols. More than one subcomponent can be present on a given Polyphenols. Examples are 
shown Figure 2 [3].            
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     Figure 2. Nomenclature of polyphenols based on phenolic subcomponent 
 
Selected Natural Compounds with Anti-Cancer Properties 
 
Naphthoquinones 
 
In recent years, some naphthoquinone derivatives such as Juglone 2 have been found to 
exhibit anti-bacterial, anti-fungal, and anti-viral properties and they could be used as anti-cancer 
agent because they can provoke cell apoptosis [4]. 
5-hydroxy-1,4-naphthalenedione (Juglone) is a naphthoquinone pigment that occurs as a 
natural product in the roots, leaves, nut, bark, and wood of black walnut (Junglans, nigra)  and 
European Walnut ( Junlars ,regia) and butter nut (Junglans, cinerea) [5]. 
Juglone is an allelopathic compound, meaning it is synthesized by one plant and affect 
the growth of another. In the case of Juglone it is toxic or growth-stunting to plants. Landscapers 
have long known that gardening underneath or near black walnut tree can be difficult. Juglone 
exerts it effect by inhibiting certain enzymes needed for metabolic functions. Nonetheless, a 
number of plants are resistant to Juglone, example fagus, Acer, and others [6]. 
Crushed unripe walnut hulls have been used for generation in various types of folk 
medicine. The hulls are made into poultices and robbed into the skin to treat bacterial or fungal 
infections such as herpes or warts. External application of black walnut also kills ring worm, and 
Chinese herbalist use this substance to kill tape worm. Juglone, due to its ability to create dark 
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orange-brown stains, has been used as coloring agent for foods and cosmetics such as hair dye. It 
is known in food industry as C.I Natural Brown 7 or C.I 75500. Traditionally Juglone has been 
used as natural dye for clothing and fabrics, particularly wool. It has also been used as Ink [5]. 
Between 1976 and 1999, 73 patent involving Juglone were obtained in the United State 
(Us patent and Trademark office, 1999). These patents demonstrated a variety of potential uses 
for juglone, for example to prepare antiviral naphthoquinone derivatives useful for AIDs 
treatment (Kurtz et al, 1996, Boyd et al, 1999). 
Flavonoids 
 Flavonoids are  group of natural occuring polyphenols that have also atrracted great 
research attention. They include several thausand compounds such  as those shown in Figure 3 
[6]. Flavonoids constitute a group of natural compounds that occur in fruits and vegetables, wine, 
and tea[7]. Scientists  in the fields of  nutritional biochemistry and medicinal chemistry have 
gained much interst in these compunds.The centre of attraction of these compounds could be 
attributed to the following reasons; first, these polyphenols exert potent anti-oxidants actions in 
numerous in vitro systems[7,12].
.
 Second,  the dietry intake of flavonoids and similar  
polyphenols exceeds that of anti-oxidative vitamins and provitamins. In epidemiologic studies, 
increase intake of flavonoids was associated with reduced risk of major cardiac events [9,10]. 
The health benefits of  flavanoids are mainly attributed to their free radical scavenging properties 
thus counterreacting conditions of oxidative stress that accompany disorders such as coronary 
artery disease, and their vascular diseases, stroke, inflamatory diseases, and cancer [9]. 
            
Figure 3. Flavonoids continued on next page 
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Figure 3. Flavonoids 
Resorcinol 
The chemistry of resorcinol is of great interest to bioorganic or natural product scientists 
due to its structural significant. The OH groups on resorcinol form hydrogen bonds to target 
molecules, holding them in a proper orientation for reaction.  Research has indicated that most 
food supplements containing resorcinol moiety have potential anti-inflammatory, anti-oxidant, 
and anti- tumor properties. Some examples of natural occurring polyphenols with resorcinol 
moiety are quercetin, kaempferol, genistein, and resveratrol as shown in Figure 4. 
Quercetin 
 Quercetin is a food supplements and it exhibit anti-inflammatory activities by inhibiting 
both manufacture of and release of Histamine and other allergic and inflammatory mediators. It 
also exerts potential anti-oxidant and vitamin C- sparing action [10].
 
Recent studies have 
supported that quercetin may help men with chronic prostatitis and both men and women with 
interstitial cystitis, possibly because of its action as mast cell inhibitor [11, 12].
 
Kaempferol  
Kaempferol is another   interesting natural flavanoid that has been isolated from tea, 
broccoli, grapefruits, apples, and other plant sources. Kaempferol consumption in tea and 
broccoli has been associated with reduced risk of heart disease [13].
 
Genistein 
 Genistein and other flavones have been found to have anti-angiogenic effects (blocking 
formation of new blood vessels) and may block the uncontrolled cell growth associated with 
cancer, most likely by inhibiting the activity of substances in the body that regulate cell division 
and cell survival (growth factors) [14]. Various studies have found moderate doses of Genistein 
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to have inhibitory effects on cancers of the prostate, cervical, brain, breast, and colon [14]. 
 University Of Califonia, Los Angeles (UCLA) cancer researchers have found that study 
participants who ate foods containing certain flavanoid seemed to be protected from developing 
lung cancer. Dr. Zuo-Feng Zhang of the UCLA's Jonsson Cancer Center and a professor of 
public health and epidemiology at the UCLA School of Public Health said the flavonoids  that 
appeared to be the most protective included catechins found in strawberries and green and black 
teas; Kaempferol, found in brussel sprouts and apples; and quercetin, found in beans, onions , 
and apples [15]. 
 
Figure 4. Compounds containing resorcinol moiety 
Chemistry of Resveratrol and Its Derivatives 
 
Resveratrol (Res) is one of the many phytoalexin producing stilbenoid present in several 
medicinal plants, grape skin, peanuts, and red wine [16]. In addition to its phytoalexin effect, it is 
also believed that it protects the plant against oxidative stress and UV radiation [17]. 
Biosynthesis of resveratrol occurs by the action of key enzyme, stilbene synthase (StSy) that 
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converts one molecule of P-coumarol-CoA and three molecules of malonyl CoA into resveratrol 
[18]. Malonyl CoA is derived by elongation of acetyl CoA units, while P-Coumaroyl-CoA from 
phenylalanine which in plants can be synthesize from sugars via Shikimate pathway [19]. 
The properties of resveratrol cannot be well understood without considering the 
chemistry of Stilbenes. Stilbenes are diarylethene and basically they are hydrocarbons consisting 
of trans or cis-ethane double bond substituted with phenyl groups on both carbon atoms of the 
double bond. They exist in two isomeric forms: The first isomer is trans-1, 2-diphenylethylene 
also known as (E)-stilbene. The second isomer is cis-1, 2-diphenylethylene commonly referred to 
as (Z)-stilbene. The Z isomer is sterically hindered and less stable because the steric interactions 
forces the aromatic rings out of plane and prevent conjugation. Cis-stilbene has melting point of 
5-6
o
C, while the trans-stilbene melts around 125
o
C [20]. 
Derivatives of Stilbene 
Many stilbene derivatives, chemically referred to as stilbenoid are present naturally in 
plants and are known to act as phytoalexins that help to improve the plant‟s defensive 
mechanism against pathogens [21]. Resveratrol and its cousin pterostilbene are examples of 
stilbenoid. Other examples that are suggested to have varied health benefits include piceatannol 
and pinosylvin .The chemistry of each mention above is discussed briefly. 
Pterostilbene  
Pterostilbene  is chemically related to resveratrol and it is thought to be the key 
compound found predominantly in blueberries (as well as grapes) that exhibit anti-cancer (breast 
cancer), hypercholesterolemia, anti-hypertriglycridemia properties as well as fight off and 
reverse cognitive decline. It is believed that the compound also has anti-diabetic properties but so 
far very little has been studied on this issue [22]. 
Unlike resveratrol, which is found in red wine, pterostilbene is not present in wine 
because it is not stable in light and air. It is also believed that pterostilbene metabolizes slowly as 
compared with resveratrol [22]. 
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Piceatannol 
3, 4, 3‟, 5‟-tetrahydroxy-trans-stilbene, commonly known as piceatannol, is a phenol 
stilbenoid. It is the metabolite of resveratrol found in red wine. LMP2A, a viral protein-
tyrosinekinase implicated in leukemia, Non-Hodgkin‟s Lymphoma, and other diseases associated 
with Epstein-Barr virus (EBV) also called human herpesVirus4 (HHV-4), was found to be 
blocked by piceatannol in vivo. These preliminary studies on piceatannol have attracted a lot of 
research attention as a potential anti-cancer and anti-EBV drug [23]. 
 
Pinosylvin 
Pinosylvin is a pre-infectious stilbenoid toxin (synthesized prior to infection) contrary to 
phytoalexins which are synthesized during infection. It is a fungi-toxin protecting the wood from 
fungal infection [24]. In 2005 S.K.Lee et al. reported that pinosylvin could exhibit more potent 
growth inhibitory activities against Candida albicans and Sacchraromyces cerevisiae compared 
to resveratrol [25]. Derivatives of pinosylvin have been reported to exhibit anti-cancer properties 
[26]. 
 
                                              
  
21 
Early Discovery and History of Resveratrol 
It is believed that resveratrol was first mentioned in Japanese article in 1939 by 
M.Takaoka, who isolated it from the poisonous but medicinal Veratrum album [27]. The name is 
presumed to have „coined‟ from resorcinol (the fact that it is resorcinol derivative) and Veratrum 
species (the plant it was first isolated from) [27]. Until today it is believed that resveratrol has 
also been isolated from roughly 70 different plant species, most important of which is the skin 
and seeds of red grapes [28]. 
Recent Studies and Applications 
Within the past decade, it has become increasingly clear that resveratrol posses 
significant health benefits to humans and could be potent chemo-preventative agent for several 
different health related problems including cancer, cardiovascular diseases, ischemia, and aging 
[29, 30]. 
Anti-Aging/Life Extension 
The fact that Res could be used as anti-aging agent attracted enormous attention 
worldwide. Here are some of captured „Res making headlines‟ 
 “The belief that aging is still an unsolved problem is longer true” - Hayflick, San 
Francisco School of Medicine. 2007 
 “The most phenomenon discovery since antibiotics” - Sinclair   Harvard University, 2003 
 “Aging as we know it may not be inevitable” - Newsweek Magazine Dec 4, 2006 
 “We may all soon be taking a pill that could give as extra decade or two of healthy old 
age” - CBS News (60 minutes), May 25, 2009 
 “Living well past 100 could actually be possible” - Barbara Walters, CBS NEWS (Live 
to 150) May 13, 2009 
The notion that aging requires treatment is because aging is a negative term that connotes 
deterioration, approaching pathology, and death [31]. 
In 2003 the groups of Howitz and Sinclair reported in the journal Nature that Res 
significantly extends the life of the yeast Sacchraromyces cerevisiae [32]. Sinclair later 
conducted some studies that showed  Res could also prolonged the lifespan of the worm 
Caenorhabdities elegans  and the fruit fly Drosophila melanogaster [33].  
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In 2007 Sinclair‟s result was reproduced by a different group of scientists using 
C.elegans [34]. Unfortunately, a third group of researches could not achieve consistent increases 
in lifespan of D.melanogaster or C.elegans [35]. The first positive result of Res supplementation 
in a vertebrate was obtained by Italian scientists in 2006. A Short-lived fish Nothobrachius 
furzeri, with a median life span of nine weeks was used .They found that a maximal dose of Res 
increased the median lifespan by 56%. The studies showed that the fish supplemented with Res 
showed significant higher general swimming activity and better learning to avoid an unpleasant 
stimulus [36]. 
Resveratrol as Anti-Cancer Compound 
Trans-Res have been reported to have multiple health related benefits to humans. Such 
health benefits include anti-inflammatory and cancer chemo-preventative potentials [37]. For the 
past few years scientists have devoted much time and resources to research the biological activity 
of Res, especially the anti-oxidant activity because  free radical-induced peroxidation of 
membrane lipids and oxidative damage of DNA have been considered to be associated with a 
wide variety of chronic health problems  such as cancer, atherosclerosis, and aging and gene 
transcription can be regulated by oxidants, anti-oxidants, and other determinants of the 
intracellular redox state[38,39,40]. 
It has also been reported that Res is a good anti-oxidant against the peroxidation of low-
density lipoprotein (LDL), liposome [41]. Research has also proven the anti-oxidant activity of 
Res is related to its hydroxyl (OH) groups which can scavenge free radicals produced in vivo 
[41]. It has also been revealed that Res has potential inhibitory effects on cyclooxygenase [37], 
rat liver mitochondrial ATPase [42], Human F1 ATPase [43, 44], and tyrosinase [45]. It is 
believed that Res is currently in clinical phase II trials as an anti-cancer drug for treatment of 
human colon cancer [46]. In addition to the above studies, Res has been shown to inhibit the 
activation of the oncogene transcription factor NF-kB by various inflammatory agents [46]. In 
1997, Jang reported that topical Res applications prevented skin cancer development in mice 
treated with a carcinogen
 
[37]. It has been reported that in vitro Res interacts with multiple 
molecular targets and damaged cells of breast, skin, gastric, colon, esophageal, prostate , and 
pancreatic cancer and leukemia [48]. 
The study of pharmacokinetics of Res in humans revealed that even high doses of Res 
might be insufficient to achieve Res concentration required for the systemic prevention of cancer 
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[49].
 
This result was consistent with the results from the animal cancer models, which indicated 
that the in vivo effectiveness of Res is limited by its poor systemic bioavailability [50, 51]. 
 
Other Suggested Applications 
 Researchers at the Weil Medical College of Cornell University came up with a report in 
2006 which indicated that dietary supplementation with Res significantly reduced plaque 
formation in animal brains, a component of Alzheimer and other Neurodegenerative diseases 
[52]. The results explained that in mice oral Res produced large reductions in brain plaque in the 
hypothalamus (-90%), striatum (-89%), and medial cortex (-48%) sections of the brain [53]. 
Researchers have come up with the theory that one mechanism for plaque eradication is the 
ability of resveratrol to chelate copper [54]. 
Anti-Inflammatory Effect  
Resveratrol (Res) is also believed to posses anti-inflammatory effects and this has been 
demonstrated in several studies using animal models. In a rat model of carrageenan-induced paw 
edema, Res inhibited both acute and chronic phases of the inflammatory process [55]. 
Cardio-Protective Effect 
Epidemiological studies have shown that cardiovascular and cerebrovascular ischemic 
events are decreased by moderate wine consumption [57]. This study is consistent with the fact 
that red wine is the most important dietary source of Res
 
[57], and it has been suggested that Res 
is at least partly responsible for the so-called „French paradox‟, which refers to the reduced 
incidence of cardiovascular diseases in region of French where saturated fats are consumed in 
even larger quantity than in US where red wine are consumed in far larger quantity [58]. It 
achieves the effects by the following functions: (1) Inhibition of vascular cell adhesion 
molecules expression,
 
(2) Inhibition of vascular smooth muscles cell proliferation, (3) 
Stimulation of endolethelial nitric oxide synthase (eNOS) activity,
 
(4) Inhibition of platelet 
aggregation, (5) Inhibition of LDL peroxidation [54, 55]. 
Anti-Diabetic Effect 
Studies have shown that resveratrol possesses hypoglycemic and hypolipidemic effects in 
both streptozotocin (STZ)-induced diabetes rats and STZ-nicotinamide-diabetes rats. Res 
ameliorate common diabetes symptoms such as polyphagia, polydipsia, and body weight loss.
 
In 
human clinical trials, resveratrol has lowered blood sugar levels in both Phases 1b and Phase IIa, 
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conducted by Sirtris Pharmaceutical, Inc
 
[58]. 
Anti-Viral Effect 
Studies show that resveratrol inhibits herpes simplex virus (HSV) types 1 and 2 
replication by inhibition of an early step in the virus replication cycle. In vivo studies in mice 
show Res inhibits or reduces HSV replication in the virgina and limits extra-virginal diseas.The 
skin of resveratrol-treated animals showed no apparent dermal toxicity such as erythema, scaling 
crusting, lichenification, or excoriation. Studies also show that resveratrol inhibits varicella-
zoster virus, certain influenza virus, respiratory viruses, and human cytomegalovirus [59]. 
Pharmacokinetics of Resveratrol 
Resveratrol seems to provide an important lead as a cancer chemo-preventative or 
chemo-therapeutic agent but pharmacokinetics studies have revealed a number of setbacks in 
relation to its absorption, metabolism, and bioavailability. Experimental results have revealed 
that one way of administering resveratrol in humans appears to be buccal delivery (without 
swallowing) by direct absorption through the inside of the mouth. This study showed that when 
one mg of Res in 50 mL solution was retained in the mouth for one min before swallowing, 
37ng/ml of free Res were measured in plasma two minutes later. It was further explained that all 
resveratrol that enters the blood circulation would be converted to molecules such as 
glucuronated and sulfate as it passes through the liver [60]. It also believed that about 70% of the 
resveratrol dose given orally as a pill was absorbed; but oral bioavailability of resveratrol was 
low because it was rapidly metabolized in intestines and liver into conjugated forms:glucuronate 
and sulfonate.The most abundant resveratrol metabolites observed in humans, rats, and mice are 
trans-resveratrol-3-O-glucuronide and trans-resveratrol-3-sulfate [61].  Walle suggested sulfate 
conjugates are the primary source of activity [62]. Wang et al. (2008) also suggested the 
glucuronides, and Boocock et al. (2007) also emphasized the need for further study of the effects 
of the metabolites. 
Mechanism of Action 
The ability of resveratrol to enhance life extension are not fully understood, but scientists 
believed that the compound appear to mimic several of the biochemical effects of calorie 
restriction. Some studies indicate that resveratrol activates Sirtuin 1(SIRT1) and PGC-1α and 
improve functioning of the mitochondria [62]. The mechanism may include direct quenching of 
reactive oxygen species, inhibition of enzymes, formation of chelates, activation of anti-oxidant 
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enzymes, etc. Scientists in the field of computational chemistry have proposed two main 
mechanisms responsible for free radical scavenging processes of chain-breaking anti-oxidant 
ArOH: 
a) H-atom transfer (1) , (b) One electron transfer (2) 
 
Scheme 1.  Free radical scavenging mechanism 
Both mechanisms are important for the scavenging activity of reactive species by an 
ArOH in a certain chemical or biological systems and may occur at the same time [63]. It is 
important to note that, in the second mechanism (one electron transfer) the Hydrogen bonding is 
normally retained as in the parent molecule contributing to a further stabilization. Resveratrol 
also acts as an anti-inflammatory agent by inhibiting cyclooxygenase (COX) activity [64] and by 
releasing cytokines from macrophages in chronic obstructive pulmonary disease (COPD). Other 
data from cell culture and animal experiments suggest that it plays a role in cancer 
chemoprevention during initiation, promotion, and progression of carcinogenesis. Resveratrol 
also inhibited the enzymes CYP1A1, CYP1A2, and CYP1B1 in tumor cells [65].         
Derivatives of Resveratrol 
Since the discovery of resveratrol in 1939, there has been intense research about this 
stilbenoid that has revealed some setbacks about the potency of this compound as chemo 
preventative agent. Studies have revealed that because of the many targets known to interact with 
Res, it is very difficult to pinpoint which targets is most important for a given disease state [66]. 
For this reason scientists are developing resveratrol derivatives that could exhibit selectivity for 
only one target. Another documented setback of resveratrol is its lack of potency and the need 
for high dosage administration; hence, there is the need to modify this compound to increase its 
potency. The problem of resveratrol having limited bioavailability has also been documented. It 
is believed that circulating resveratrol has a serum half-life of 8-14 min because it is rapidly 
metabolized by sulfation and glucuronation [67]. Res 3-sulfate and res 3-glucuronide, the two 
primary metabolites of resveratrol, have both been shown to exhibit far lower affinity for COX-1 
and COX-2 [68].  
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It is been suggested that for resveratrol to be effectively used as a chemotherapeutic 
agent, modified analogues with comparable activity that lack the hydroxyl groups and hence 
could not be sulfated or glucuronated must be synthesized [69]. 
Aliphatic acids and their ester or ether derivatives of resveratrol have been found to 
possess good water solubility and increased bioavailability as shown in Figure 5. Jiang reported 
that compounds 1a and 1b did not show any improved solubility when measured in either water 
or phosphate buffer compared to their aliphatic acids 2a and 2b which showed improved water 
solubility (PH 7). Jiang also reported that the binding affinity of compound 2a and 2b for Human 
serum albumin (HSA) was higher than that of Res and as the number of chain of the aliphatic 
acid group increases so as the binding affinity [70]. 
 
 
Figure 5.  Derivatives of resveratrol by Jiang [70] 
  
In 2007 Huang et al. reported that methylation of three hydroxyl groups of trans-Res 
could improve the anti-tumor activity .They suggested the increased cytotoxic activities of the 
modified Res could be attributed to the increased lipophilic activity of these compounds, which 
might increase the permeability of the cell membranes, Figure 6 .They also concluded that 
compound with alkyl ring amino side chains 3a and 3b showed better cytotoxic activities than 
those containing aromatic ring, 3c. Compound 3d was found to show the highest anti-tumor 
activity but they could not explain this observation [71]. 
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Figure 6. Derivatives of resveratrol by Huang et al.
 
[71]
 
Chemical Synthesis of Resveratrol 
Most medicinally important polyphenols occurs naturally in plants and effort to isolate 
them in their natural form is a problem due to insufficient and complex technological procedures. 
In view of this, there is the need to encourage synthetic analogues of these compounds. There 
have been several synthetic pathways to produce resveratrol and two of them have been outlined 
in Schemes 2 and 3. Scheme 2 was developed by Polunin et al. [72]. Scheme 3 was developed by 
Mingfu Wang et al. [73]. 
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Scheme 2. Chemical synthesis of resveratrol by Polunin et al. 
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Scheme 3. Chemical synthesis of resveratrol by Mingfu Wang et al. 
 
Purpose of this Research 
The fundamental objective of this research is to synthesize a water soluble anti-cancer 
compound. Low water solubility and low bioavailability of chemotherapeutic agents are some of 
the big challenges facing synthetic organic chemists and most pharmaceutical industries. 
Derivatives and analogues of potential chemo preventative compounds are being synthesized and 
evaluated to ascertain their bioavailability and water solubility. In this research, attempt was 
made to modify Juglone into water soluble derivative, but we could not reproduce the result and 
therefore there was the need to change the direction of the research to include modification of 
resveratrol. 
Proposed Synthetic Pathway for Synthesis of Juglone 
The synthesis of Juglone 2 was a cupper catalyzed oxidation of dihydroxynaphthalene 1 
as outlined in Scheme 4 [74]. 
 
 
 
Scheme 4. Synthesis of Juglone 
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Scheme 5. Mechanism for oxidation of 1, 5-dihydroxynaphthalene 
 
Proposed Synthetic Pathway for Modification of Juglone 
Two synthetic schemes were employed as part of the efforts to modify Juglone: Scheme 
6 and Scheme 8. Scheme 6 involved room temperature esterification of juglone using Boc- 
protected amino acids in the presence of DicyclohexylCarbodiimide (DCC) and 
Dimethylaminopyridine (DMAP). The purpose of using DCC and DMAP is to activate the Boc 
protected amino acid which will ensure SN2 attack by the alcohol group (Scheme 7). This 
pathway was not successful and it was therefore abandoned. Scheme 8 is based on Williamson‟s 
ether synthesis using bromoester as the alkylating agent. Weak base K2CO3 was used to 
deprotonate the hydroxyl group of the Juglone to form phenoxide which was then alkylated with 
the bromo ester via SN2 mechanism (Scheme 9).  
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Scheme 6. Room temperature esterification of Juglone 
 
 
          
Scheme 7. Mechanism for Room Temperature Esterification of Juglone 
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                                            Scheme 8. Modification of Juglone by Williamson Etherification 
   
 
Scheme 9. Mechanism for Williamson Ether Synthesis 
 
Proposed Synthetic Pathway for Modification of Resveratrol 
Modification of the trans-Res was performed by selective alkylation of para-OH group 
using Williamson‟s ether synthesis approach to obtain the mono alkylated product. (Mechanism 
is similar to Scheme 9). The phenoxide form from deprotonation of para hydroxyl-group is more 
stable compared to that of meta-proton abstraction as indicated by resonance structures in 
Scheme 11 and 12 respectively.  
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Proposed Synthetic Pathway for Synthesis of Methyl 4-Bromobutyrate  
 
Compound 6 was synthesized by employing Fisher esterification reaction between 4-
bromobutyric acid and methanol as shown in Scheme 13.                      
 
Scheme 13.  Synthetic Pathway for 4-Bromomethylbutyrate by Fischer esterification 
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Scheme 14.  Mechanism for Fischer esterification 
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CHAPTER 2 
RESULTS AND DISCUSSION 
 
Synthesis of 5-hydroxy-1, 4 -naphthoquinone (Juglone) 2 
 
 
Compound 2 was obtained as orange crystals after purification of the crude product 
using soxhlet extraction method based on the previous reported method [74]. A moderate yield 
of 30% was obtained that is relatively lower than the reported yield of 33% [74]. The oxidation 
reaction occurs by free radical mechanism as shown in Scheme 5. 
 
Synthesis of Methyl 5-[(1, 4-naphthenedionyl) oxy]-acetate 4 
 
The synthesis of this compound was based on the theory of Williamson‟s ether synthesis 
where the base reacts to form the phenoxide. The phenoxide reacted with the bromoester to yield 
30% product (Scheme 8). Unfortunately this procedure could not be reproduced. For this reason 
there was the need to change the direction of our research to include resveratrol. 
 
Synthesis of Methyl 4-Bromobutyrate 6 
 
        In order to synthesize our novel Res derivative, there was the need to synthesize the 
alkylating agent 6. A white-yellow liquid was obtained by reaction of the bromobutyric acid with 
methanol catalyzed by sulfuric acid. The reaction mechanism followed the Fisher esterification 
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reaction as shown in Scheme 13. 
Synthesis of Methyl 4-{-[(1E)-2-(3, 5,-dihydroxyphenyl)-ethenyl] - phenoxy} butyrate 7 
 
Compound 7 was obtained as white solid crystals with low yield of 10%. The low yield 
could be attributed to highly competitive side products such as di and tri alkylated products. The 
regiochemistry of the alkylating step is very crucial for selective product formation. Effort was 
made to control selectivity of alkylation by varying reaction conditions, and the summary of 
results is shown in Table1. 
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Table 1. Summary of Reaction Results 
 
RES 
      (mol 
ratio) 
K2CO3 
(mol ratio) 
Br(CH2)3COOMe 
(mol ratio) 
Temperature 
(
o
C) 
Mono 
(%) 
Di 
(%) 
Tri 
(%) 
Recovered 
(RES) (%) 
Reaction Time 
(Hrs) 
 
1 
 
2 
 
1 
 
≥70 
 
None 
 
None 
 
80 
 
20 
 
12 
 
1 
 
2 
 
1 
 
25 
 
None 
 
None 
 
None 
 
100 
 
12 
 
1 
 
1.5 
 
0.7 
 
60 
 
3 
 
25 
 
30 
 
42 
 
12 
 
1 
2 
2 
 
1 
 
50 
 
10 
 
35 
 
20 
 
       35 10 35 20 35 
 
12 
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               Millimole amount of the alkylating agent and reaction temperature were the two main 
factors controlling selectivity. At high temperatures the selectivity was low and tri alkylated 
product was mainly the product. It was observed that at room temperature there would be no 
reaction. The best temperature for the reaction was found to be 50
o
C. It was also found that the 
molar equivalent ratio of 1:2:1 with respect to resveratrol, potassium carbonate, and the bromo 
ester was suitable for the reaction. It was observed that addition of the bromoester in dropwise 
was very important for controlled selectivity. It must be noted that in all the cases tri and di 
alkylated products were separated. Another interesting observation was the fact that the mono 
alkylated product is present in two forms: mono alkylation occurring at the meta position 
together with the expected mono alkylated product at para position. This was revealed by        
H 
NMR (Appendix E) after column purification and hence recrystalization method was used to 
purify the product.  
Conclusion 
 The objective of the research was partly fulfilled due to time constrain by synthesizing a 
novel intermediate (compound 7) that could be subjected to further chemical transformation to 
obtain the amino acid derivatives. The low yield (10%) was attributed to the competitive side 
reactions and also the need to recrystallize the product to remove the isomer that was present 
even after column purification. We also made an effort to determine the best condition to reduce 
side reactions in other to improve the yield. The result obtained could be useful for future 
experimentation to obtain a better yield. 
  It must be noted that Juglone was also synthesized based on the initial objective in 
relatively good yield 30% (reported yield of 33%). It should be noted that one of the factors that 
was affecting the reaction to obtained compound 4 was hydrogen bonding between the H of 
hydroxyl group and the carbonyl oxygen group on the Juglone structure 2. Reaction temperature 
must be carefully studied to overcome the hydrogen bonding in other to obtain good results. 
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CHAPTER 3 
EXPERIMENTAL 
General Methods 
Resveratrol and other commercial reagents were used without further purification and 
were purchased from sigma (St.Louis, MO, USA). All proton (
1
H) and carbon (
13
C) NMR 
spectra were recorded on JEOL‐NMR Eclipse spectrometer operating at 400 MHz and 100 MHz 
for proton and carbon nuclei respectively. Spectra were obtained using CDCl
3 
unless otherwise 
stated. Chemical shifts were recorded as delta values in parts per million (ppm) relative to TMS. 
The multiplicity of signals is reported as follows: s, singlet; d, doublet; m, multiplet. Thin layer 
chromatography (TLC) was performed with silica gel plate using appropriate solvent mixture 
and visualized under UV Fluorescent indicator. Column chromatography was performed using 
silica gel and appropriate solvent. Melting points were recorded on Cambridge MEL-TEMP 
instruments and were not corrected. All weighing were done using Mettler PJ360 Delta Range 
scale unless otherwise stated. 
Experimental Procedures 
Synthesis of 5-hydroxy-1, 4-naphthoquinone (Juglone) 2 
 
A suspension of 1.2 g (0.012 mol) CuCl in acetonitrile (150 mL) was placed in three-necked 
flask. A strong current of air was bubbled through it. A suspension of 1, 5-dihydroxynaphthalene 
(3.0 g, 0.019 mol) in acetonitrile (150 mL) was added with vigorous stirring at room temperature 
in a dark over 30 min, and the resultant mixture stirred for 7 h. The mixture was filtered and 
washed with acetonitrile and the solvent removed under reduced pressure. Soxhlet extractor was 
used to purify the crude using n-heptane as solvent to give 2 (0.36 g, 30%) as an orange solid 
[74]. The reported yield was 33%, M.p 155-159
o
C; Lit M.p 154-161 
o
C.
 1H
NMR (400 MHz, 
CDCl3): δ 6.94 (s, Ar-H) 7.29 (dd, J=6.3, 2.9Hz); 7.64 (m, Ar-H); 11.9 (s, OH); 
13
CNMR (100 
MHZ, CDCl3) δ 115.05, 119.27, 124.64, 131.83, 136.68, 138.76, 139.69, 161.53, 184.37, 190.40 
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Synthesis of Methyl 4-Bromobutyrate 6 
 
To a one-neck round-bottomed flask were added 5 g (0.03 mol) 4-bromobutyric acid, 
twenty-five milliliters of methanol was added followed by 2 drops of sulfuric acid and the 
mixture was reflux for 16 hrs (60
o
C). The mixture was concentrated, washed with 5% NaHCO3, 
and extracted with diethyl ether. The extract was dried with MgSO4 (anhydrous) and the ether 
was evaporated to afford 4.7 g (94%) 6. 
1
H NMR (400 MHz, CDCl3) δ 3.65 (s, 3H, OCH3); 3.45 
(t, 2H, CH2); 2.49 (t, 2H, CH2); 2.17 (m, 2H, CH2). 
Synthesis of Methyl 4-{-[(1E)-2-(3, 5,-dihydroxyphenyl)-ethenyl]-phenoxy} butyrate 7 
 
To a one-neck round bottomed flask were added 0.3 g (1.3 mmol) resveratrol, 15 mL 
acetone, and 0.36 g K2CO3 (2.8 mmol). 0.235 g (1.3 mmol) of compound 6 was added in 
dropwise( 50% added initially and stirred for 6 hrs and the remaining half added and stirred for 
the next 10 hrs) at the temperature of 50
o
C. The mixture was decomposed with concentrated 
ammonium chloride, extracted with ethyl acetate, and dried with anhydrous MgSO4.  The solvent 
was evaporated and the resulting mixture was purified using column chromatography (25-40% of 
acetone in hexane volume) to give compound 7 (0.03 g, 10%). The compound was recrystallized 
from ethyl acetate hexane (1:10 volume) to obtain 0.02 g, (6.7%), RF   value 0.65 (Acetone 
/hexane 40:60 v/v). Mp.148-150
o
C. 
1
HNMR  (CD3COCD3, 400 MHz, ppm)  δ  2.038 (t, 2H, 
CH2); δ 2.5 (m, 2H, CH2); δ 3.6 (s, 3H,CH3); δ 4.03 (t, 2H, OCH2); 8.2 ( s, 2H, OH); 7.5 ( d, 2H, 
Ar-H), 6.94 (m, 4H, Ar-H );  6.5  (s, 2H, Ar-H);  6.29  (s, 1H, Ar-H);  
13
C NMR (CD3COCD3 
,100 MHz ,ppm) δ  28.6,  50.8,  66.7,  101.95,  104.91, 114.68, 126.7, 127.8, 127.9, 130.23, 
139.9, 158.78, 173.00. 
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